BREAKOUT ABOVE 52 WEEK HIGH IN SUVEN-- EDUCATIONAL PURPOSESuven Life Sciences LimitedNSE:SUVENmgvirus1Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Stock made high of 300 in July 2025, after that it crashed down to 124 till Mar 2026 (-58%) correction in 9-10 months. Then it started to grow and touched previous high in June 2026. After small correction stock successfully closed above previous high this week. This is breakout above 52 week high and also confirmed higher high -higher low structure. Long position can be initiated on re test level near 292-295. TARGET : 652 (121%) (FIBO) STOP LOSS : 230 (-21%) ON WEEKLY CLOSING BASIS RR RATIO : 1:5.6 TIME HORIZON :5-6 YEARS (TILL 2032) ONLY FOR INVESTMENT PURSPECTIVE, NOT FOR SHORT TERM TRADING